Human GIPR Gastric Inhibitory Polypeptide Receptor EZCells™

Double click on above image to view full picture

Zoom Out
Zoom In

More Views

  • Intracellular cAMP response from CHO-K1 cells stably expressing the GPR119 receptor, either irradiated (green) or non-irradiated (blue). Cells were stimulated with the indicated concentrations of GIP for 30 min at 37oC along with 0.5 mM IBMX, then cells were assayed for cAMP content using the HitHunter kit (DiscoveRx). Data represent the average +/- standard deviation of triplicate determinations.

Human GIPR Gastric Inhibitory Polypeptide Receptor EZCells™

  • Cat.#:
  • A495
  • Lot #:
  • 913

Availability: In stock

Price: $275.00
Add Items to Cart
OR

Quick Overview

Human GIPR Gastric Inhibitory Polypeptide Receptor-expressing GPCR (G protein-coupled receptor) division-arrested cells. Gastric inhibitory polypeptide (GIP) is a 42-amino acid polypeptide synthesized by K-cells of the duodenum and small intestine. GIP’s principle physiological action is to stimulate insulin secretion from pancreatic β-cells in a glucose-dependent manner. Additional effects of GIP have been described, including effects on lipid metabolism, stimulation of glucagons and somatostatin release. GIP exerts its effects by binding to its specific receptor, the GIP receptor which belongs to the VIP/glucagon/secretin family of G protein-coupled receptors and is positively coupled to adenylyl cyclase but not to phospholipase C.

Background

Gastric inhibitory polypeptide (GIP) is a 42-amino acid polypeptide synthesized by K-cells of the duodenum and small intestine. GIP’s principle physiological action is to stimulate insulin secretion from pancreatic β-cells in a glucose-dependent manner. Additional effects of GIP have been described, including effects on lipid metabolism, stimulation of glucagons and somatostatin release. GIP exerts its effects by binding to its specific receptor, the GIP receptor which belongs to the VIP/glucagon/secretin family of G protein-coupled receptors and is positively coupled to adenylyl cyclase but not to phospholipase C.
General Info
Synonyms glucose-dependent insulinotropic peptide receptor
Product Description Human GIPR Gastric Inhibitory Polypeptide Receptor-expressing GPCR (G protein-coupled receptor) division-arrested cells. Gastric inhibitory polypeptide (GIP) is a 42-amino acid polypeptide synthesized by K-cells of the duodenum and small intestine. GIP’s principle physiological action is to stimulate insulin secretion from pancreatic β-cells in a glucose-dependent manner. Additional effects of GIP have been described, including effects on lipid metabolism, stimulation of glucagons and somatostatin release. GIP exerts its effects by binding to its specific receptor, the GIP receptor which belongs to the VIP/glucagon/secretin family of G protein-coupled receptors and is positively coupled to adenylyl cyclase but not to phospholipase C.
Target Type GPCR
Product Type EZCells™ DA
Receptor Gastric Inhibitory Polypeptide
Sub-Type GIPR
Therapeutic Area metabolic & gastrointestinal
Related Services Membrane Preparation, GPCR Screening
Genbank Accession Number NM_000164
Validated Assay/Platform binding, cAMP
References Usdin, T., et al (1993) Gastric Inhibitory Polypeptide Receptor, a Member of the Secretin-Vasoactive Instestinal Peptide Receptor Family, Is Widely Distributed in Peripheral Organs and the Brain. Endocrinology 133(6): 2861-70.
EZCell Info
Host cell CHO-K1
Mycoplasma Status Negative (MycoAlert Kit)
Growth media Ham's F12, 10% FBS, 1% NEAA, 500 µg/mL G418
Storage and Packaging
Packaging Cryopreserved irradiated cells, 6 million cells per vial
Storage Recommendation liquid nitrogen
Quantity 6 million cells
Media
Specification Sheet  Download PDF Document